Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

CardioCell

- PMLiVE

UK unveils new antibiotic buying plan, pharma incentives

Health minister compares upfront payment model to Spotify

- PMLiVE

Advaxis shaken by another FDA hold on cervical cancer vaccine

Suspends enrolment into pivotal phase 3 trial

- PMLiVE

EMA says Lilly’s Lartruvo should not be prescribed

First time EMA has acted on accelerated approval follow-up

Why precision medicine demands precision engagement

The speed of innovation brings its own challenges, says cloud computing expert

- PMLiVE

Researchers reverse Alzheimer’s memory loss in mice

Epigenetics opens up new potential drug targets

- PMLiVE

J&J earnings top expectations, but feels the squeeze in US

Blockbuster Xarelto declines 14% due to US competition

- PMLiVE

Editas CEO exits the CRISPR firm ahead of first clinical trial

Shares in company and competitors sink

- PMLiVE

UniQure cleared to start Huntington gene therapy trial

AMT-130 becomes the first AAV-based therapy approved for trials in Huntington’s disease

A dynamic and challenging environment – what it’s like starting a career in MedComms

Ayala Donegan discusses her #LucidLife journey into #MedComms

Lucid Group Communications Limited

HSJ Partnership Awards 2019 shortlist announced

The finalists for the HSJ Partnership Awards have been announced today ahead of a prestigious black-tie dinner awards ceremony at Park Plaza, Westminster Bridge on 20 March 2019.

Wilmington Healthcare

- PMLiVE

Unlocking the potential of science and technology in the UK

Greater collaboration is vital in post-Brexit UK, says Alderley Park leader

Unlocking the potential of science and technology in the UK

Greater collaboration is vital in post-Brexit UK, says Alderley Park leader

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links